Safety Profile of NMN (Nicotinamide Mononucleotide)

Evidence Limitations: The safety evidence for NMN is extremely limited. The provided research consists primarily of preclinical animal studies and early-phase human trials with unknown or incomplete status, providing insufficient data to establish a comprehensive safety profile.

Known Side Effects

Evidence is insufficient to characterize the side effects profile of NMN in humans. The available studies focus on mechanistic research in cellular and animal models rather than systematic safety evaluation in human populations.

Contraindications

No specific contraindications have been established based on the available evidence. The research provided does not include safety data sufficient to identify populations or conditions where NMN should be avoided.

Drug Interactions

Drug interaction data is not available in the provided evidence. None of the studies examined potential interactions between NMN and other medications or therapeutic compounds, with the exception of one study investigating combination therapy with Elamipretide (SS-31) in mice.

Populations That Should Exercise Caution

Insufficient evidence exists to identify specific populations that should avoid NMN. However, the following considerations apply:

• Pregnant and breastfeeding women: No safety data available
• Children and adolescents: No pediatric safety studies identified
• Individuals with chronic medical conditions: Safety profile unknown in disease populations
• Elderly populations: While some research focuses on aging-related applications, comprehensive safety data in older adults is lacking

Clinical Trial Safety Data

The provided clinical trials include several completed or ongoing studies, but safety outcomes and adverse event data are not available in the evidence provided. Trial statuses are listed as "UNKNOWN" for most studies, limiting the ability to assess safety findings.

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using NMN, especially if you have underlying health conditions or take other medications. The limited safety data available emphasizes the importance of medical supervision when considering NMN supplementation.